Manager, Corporate Affairs Intelligence, Emerging Issues
Novartis
Summary
What is about to change in the world around Novartis, and what could it mean for us? In this role, you'll scan politics, economics, society, regulation, geopolitics, technology and new business models for early signals, and trace their second- and third-order effects. You'll give Corporate Affairs the foresight to prepare before issues take shape.
Job description
Key Responsibilities
- Identify meaningful and non-obvious signals, patterns, contradictions, evidence gaps, connections, potential inflection points, and preliminary first-, second-, and third-order implications across political, economic, societal, regulatory, geopolitical, technological, and cross-industry developments.
- Connect external developments and potential inflection points to how the biopharmaceutical landscape may change and to the audiences, narratives, relationships, and influence networks likely to shape their impact on Novartis.
- Maintain assigned areas of Corporate Affairs Intelligence's emerging issues foundation, preserving signals, drivers, issue categories, geographies, policy and regulatory developments, potential inflection points, scenarios, evidence, context, assumptions, methods, findings, and analytical learning for reuse across briefs.
- Collect, structure, validate, and analyze quantitative and qualitative information from diverse sources, including traditional and social media, financial and corporate disclosures, policy and regulatory materials, scientific literature, stakeholder communications, public web content, blogs, forums, and other digital information environments, ensuring evidence is accurate, objective, traceable, and appropriate for the analytical question.
- Synthesize evidence into clear findings and evidence-based preliminary judgments and points of view, distinguishing supported conclusions from assumptions, uncertainties, and questions requiring further analysis or escalation.
- Apply AI-enabled workflows responsibly to improve analytical speed, rigor, and depth; validate AI-generated outputs against trusted evidence; and document improvements to prompts, methods, and workflows.
- Engage Corporate Affairs stakeholders at the project level to gather context, clarify how intelligence may be used, test understanding, and communicate findings while preserving analytical objectivity.
- Strengthen Corporate Affairs Intelligence's collective intelligence by producing objective, evidence-based work; communicating complex ideas clearly; seeking feedback; and collaborating across roles, workstreams, and functions.
Essential Requirements
- Bachelor's degree and relevant experience in intelligence, foresight, policy or analytical fields.
- Experience analyzing government, policy and regulatory sources; political and economic reporting; scientific literature; technology and cross-industry developments; and traditional and social media.
- Experience managing analytical work from research planning and evidence collection through validation, synthesis and evidence-based conclusions.
- Ability to identify early signals, trends and implications across political, economic, societal, regulatory, geopolitical and technological developments.
- Experience analysing structured and unstructured information across policy, regulatory, scientific, corporate, media and digital sources.
- Hands-on experience using research, monitoring, data, intelligence or artificial intelligence-enabled tools and workflows.
- Strong analytical thinking and business acumen, connecting external developments to enterprise and Corporate Affairs priorities.
- Ability to communicate complex findings clearly, objectively and effectively to stakeholders across teams and functions.
- Intellectual curiosity, sound judgement and confidence working independently in complex, evolving and ambiguous environments.
Requirements
- Bachelor's degree and relevant experience in intelligence, foresight, policy or analytical fields.
- Experience analyzing government, policy and regulatory sources; political and economic reporting; scientific literature; technology and cross-industry developments; and traditional and social media.
- Experience managing analytical work from research planning and evidence collection through validation, synthesis and evidence-based conclusions.
- Ability to identify early signals, trends and implications across political, economic, societal, regulatory, geopolitical and technological developments.
- Experience analysing structured and unstructured information across policy, regulatory, scientific, corporate, media and digital sources.
- Hands-on experience using research, monitoring, data, intelligence or artificial intelligence-enabled tools and workflows.
- Strong analytical thinking and business acumen, connecting external developments to enterprise and Corporate Affairs priorities.
- Ability to communicate complex findings clearly, objectively and effectively to stakeholders across teams and functions.
- Intellectual curiosity, sound judgement and confidence working independently in complex, evolving and ambiguous environments.
Benefits
- Health insurance
- Life insurance
- Disability benefits
- 401(k) matching
- Paid time off
- Vacation
- Personal days
- Holidays
- Performance-based cash incentive
- Annual equity awards
Company overview
Novartis is a global pharmaceutical company headquartered in Basel, Switzerland, dedicated to reimagining medicine to improve and extend people's lives. As an innovative medicines company, Novartis focuses on developing high-value treatments that address society's greatest disease burdens through technology leadership in research and development. The company operates across five core therapeutic areas: cardiovascular, renal and metabolic diseases; immunology; neuroscience; oncology; and hematology. With a workforce of approximately 75,883 employees worldwide, Novartis reaches nearly 300 million patients across 118 countries. The company leverages advanced technology platforms including targeted protein degradation, cell therapy, gene therapy, radioligand therapy, and xRNA to develop breakthrough treatments. Novartis maintains a strong portfolio of oncology drugs and generics while continuously expanding its pipeline through strategic acquisitions and internal research. The company's commitment extends beyond drug development to ensuring global access to medical innovations through novel access approaches and patient assistance programs.